Apr 03, 2025 اردو ► PRINT EDITION ► BR MARKETS ► Dollar to PKR ►

Oxford vaccine

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s
World

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

  • "We are not advising a stop to any vaccination for any individual in any age group. We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution, rather than because we have any serious safety concerns," he said at a briefing. It came after Britain's MHRA medicine regulator identified a possible side-effect from the COVID-19 vaccine developed by Oxford University and AstraZeneca involving rare brain blood clotting.
Published 07 Apr, 2021 08:09pm
AstraZeneca/Oxford vaccine more effective with longer dose gap: study
Business & Finance

AstraZeneca/Oxford vaccine more effective with longer dose gap: study

  • The study confirmed the Anglo-Swedish drugmaker's findings from earlier this month that showed the vaccine had 76% efficacy against symptomatic coronavirus infection for three months after the first dose.
  • Efficacy was found to be at 81% with the longer interval of 12 weeks between the first and second dose, compared with 55% efficacy up to the six-week gap.
Published 19 Feb, 2021 09:17pm
South Africa offers AstraZeneca jabs to AU
World

South Africa offers AstraZeneca jabs to AU

  • "The first batch of Johnson & Johnson Covid-19 vaccines have arrived at OR Tambo International Airport," Mkhize tweeted as the precious cargo landed in the financial capital Johannesburg.
Published 17 Feb, 2021 11:06am